#DPCO – Vaayath

VISIT PHARMINHO

Discover regulatory status of 14000+ drugs

Access 15+ regulatory services

Structured insights, and compliance clarity—all in one place

Skip to content

Email:vaayath@gmail.com
Call Now:-+91 6280051677

Home
Services
About Us
Why Us
Blog
Testimonials
contact Us

X

Please Enter Your Number

Tag: #DPCO

Vaayath > #DPCO

admin
August 5, 2026
Pharma News

Share Now

DPCO (Amendment) Order, 2026: Overcharging Liability Relief for Pharma manufacturers

DPCO Amendment 2026: Overcharging Liability, Record Retention & Form-IA S.O. 3516(E) | Dated 30 June 2026 The Department of Pharmaceuticals rewrites Paragraphs 24 and 29 of the Drugs (Prices Control) Order, 2013 — and introduces a new intimation proforma for…

Read More

Recent Post

DPCO (Amendment) Order, 2026: Overcharging Liability Relief for Pharma manufacturers
CDSCO Directs Ibuprofen Manufacturers to Add ‘Fixed Drug Eruption’ to PILs
No Registration Certificate, No Entry for Imported Cosmetics
CDSCO Clarifies Jurisdiction for Compounding of Offences Applications
CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)

Vaayath is a leading provider of comprehensive pharma regulatory services, serving as a one-stop destination for all your regulatory needs. With a focus on excellence and a commitment to delivering outstanding results

Quick Links

Home
About us
Why us
Blog
Contact Us

Services

Pharma Regulatory Services
Pharma GMP Services
Pharmacovigilance Services

Contacts

SCO 15-16, Second Floor, Shri Balaji Complex, old Ambala Road, Dhakoli, Zirakpur, SAS Nagar , Punjab, 160104

+91 6280051677

info@vaayath.com

Recent Posts

DPCO (Amendment) Order, 2026: Overcharging Liability Relief for Pharma manufacturers
CDSCO Directs Ibuprofen Manufacturers to Add ‘Fixed Drug Eruption’ to PILs
No Registration Certificate, No Entry for Imported Cosmetics
CDSCO Clarifies Jurisdiction for Compounding of Offences Applications

×